[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"brand-deyuanyaoye":3},{"head":4,"company":40,"invest":45,"children":46,"shops":47,"category":48,"sameIndustry":5,"rid":6},{"createTime":5,"updateTime":5,"createBy":5,"updateBy":5,"brandId":6,"brandLogo":7,"brandImage":5,"brandName":8,"webName":9,"balias":5,"enterId":10,"mainindustry":11,"industry":5,"brandType":12,"brandHonor":5,"brandTel":13,"establishdate":14,"brandBirth":15,"cityarea":5,"brandWebsite":5,"brandSobp":5,"brandVisit":5,"totalVisits":16,"status":17,"isDeleted":17,"comment":5,"remark":5,"logoExistStatus":18,"imageExistStatus":18,"industryId":5,"industryRanking":5,"score":5,"enterName":19,"mallShopList":20,"brandSummary":5,"likes":5,"unlikes":5,"follow":5,"pagetitle":21,"pagekeywords":22,"pagedesc":23,"brandContent":24,"province":5,"city":5,"area":5,"detailaddress":25,"unifiedscc":26,"enterType":27,"enterLegalperson":28,"enterStablishdate":29,"regauthority":30,"licenseValidity":31,"approvaldate":32,"regcapital":33,"incapital":34,"businessscope":35,"ownBrand":5,"enterTelphone":36,"enterWebsite":37,"business":38,"enterQq":5,"enterMail":39,"bindUser":5,"enterMployeenum":5,"regcapitalunit":5,"abnormal":5,"yeartax":5,"regtrademark":5},null,"94369","\u002Fprofile\u002Fupload\u002F2023\u002F12\u002F02\u002Fb2da52861b15899d7182411c20aac090.gif","德源药业","deyuanyaoye",94043,5593,3,"0518-82342965","2004年","连云港市",401,0,"1","江苏德源药业股份有限公司",[],"德源药业简介-德源药物-品牌之家","德源药业品牌介绍,德源药物好不好,德源怎么样,德源,江苏德源药业股份有限公司","德源药业品牌简介，品牌之家为你介绍江苏德源药业股份有限公司旗下德源药业品牌信息，包括品牌介绍、联系方式、主营产品、最新评论、点赞数量等，告诉你德源药物怎么样，致力于帮助你了解德源药业真实有效的品牌相关信息。","德源药业成立于2004年，是一家专注于内分泌治疗药物研发、生产、销售的现代化制药企业，已发展成为国内有一定知名度的内分泌疾病、代谢综合征等慢病药物供应商，被认定为“国家高新技术企业”。公司于2021年成为北京证券交易所上市企业，股票代码：832735，股票简称：德源药业。\n\n公司拥有资产10.5亿元，占地面积25.8万平方米，分别建有一工厂、二工厂，三工厂项目建设正在稳步推进，并设立了南京德源药业有限公司。公司产品涉及糖尿病、高血压、周围神经病变、膀胱过度活动症和罕见病等治疗领域，拥有化学药品注册批件18个，原料药注册批件2个，另有6个原料药批准在上市制剂中使用。\n\n公司在售品种为：原国家1类新药瑞彤（盐酸吡格列酮片），原国家2类新药唐瑞（那格列奈片），原国家3类新药复瑞彤（吡格列酮二甲双胍片）、波开清（坎地氢噻片），盐酸二甲双胍缓释片、依帕司他片、阿卡波糖片、琥珀酸索利那新片、安立生坦片、甲钴胺胶囊等。卡格列净片、恩格列净片等已获得生产批件，目前正在进行上市销售前的准备工作。公司产品的一致性评价工作有序推进，主要品种均通过或视同通过一致性评价。\n\n公司坚持“以仿为主、仿创结合、以仿养创”的研发策略，高度重视产品研发及技术储备工作，近年来研发费用投入占营业收入比例均超过10%。公司以博士、硕士学历人员为主要研发力量，已建立相对完善的研发体系，在不断完善现有产品群的同时，向糖尿病并发症、膀胱过度活动症、痛风及高尿酸血症等其他慢病、老年病领域扩展。公司还积极与国内各大科研院所、高校密切合作，持续增大研发投入，力求保持企业持久的科技创新发展能力。\n\n秉德践信、正源至善。未来，德源药业将继续“为患者寻找和提供更安全、更有效的药物，奉献于人类的健康和幸福”的企业使命，努力践行“德济苍生、源远流长”的企业愿景。","连云港经济技术开发区长江路29号","913207007665096280","股份有限公司(上市)","陈学民","2004-10-29","连云港市工商行政管理局","-","2024-11-08","7,821.066万(元)","3,000万(元)","片剂、硬胶囊剂、原料药（盐酸吡格列酮、那格列奈）的研发、生产。（依法须经批准的项目，经相关部门批准后方可开展经营活动）******","0518-82342957","www.pharmdy.com","医药制造业","pharmdy@163.com",{"enterId":41,"enterName":19,"province":5,"city":5,"area":5,"detailaddress":25,"unifiedscc":26,"enterType":27,"enterLegalperson":28,"enterStablishdate":29,"regauthority":30,"licenseValidity":31,"approvaldate":32,"regcapital":33,"incapital":34,"businessscope":35,"ownBrand":5,"enterTelphone":36,"enterWebsite":37,"business":38,"performance":42,"socialSecurity":43,"registrationNumber":44,"enterQq":5,"enterMail":39,"bindUser":5,"enterMployeenum":5,"regcapitalunit":5,"abnormal":5,"yeartax":5,"status":17,"regtrademark":5,"remark":5},"94043","开业","878人","320791000009813",{"createTime":5,"updateTime":5,"createBy":5,"updateBy":5,"id":5,"brandId":5,"brandName":5,"busmodel":5,"franchiseFund":5,"totalStores":5,"devmodel":5,"franchiseIndustry":5,"investmenttel":5,"suitablePeople":5,"state":5},[],[],[49],{"createTime":50,"updateTime":51,"createBy":5,"updateBy":5,"industryId":52,"webId":5,"industryName":53,"industryAlias":54,"industryIcon":5,"industryTrans":55,"pageTitle":56,"pageDesc":57,"pageKeywords":58,"mainTitle":59,"pageSubtitle":60,"indSummary":61,"industryLevel":12,"parentId":62,"parentName":63,"sortOrder":64,"status":17,"classifyVisit":65,"totalVisits":66,"searchName":5,"starLevel":5,"limit":5},"2000-01-01 00:00:00","2026-06-14 16:50:00","5593","药品","药品,药物,医药制剂,医疗药品,医用药品,药片","\u002Fprofile\u002Fupload\u002F2023\u002F11\u002F08\u002F175454c1767ce2414a13f8c3c16194de.png","十大药品品牌-药品十大厂家-ZGALL品牌榜","2026年药品行业十大品牌权威发布！药品排行榜前十名品牌有三九、同仁堂、广药白云山、云南白药、太极药业、修正、念慈菴、天士力、扬子江药业、仁和。药品10大品牌由品牌中国重磅推出，旨在呈现行业领域标杆品牌，展现行业优秀企业实力，帮助你了解药品哪个牌子好。","药品十大品牌排名,OTC药品十大品牌,非处方药品牌十大排行榜,OTC药品排行,药品品牌有哪些","药品品牌排行榜","2026药品品牌排行榜，OTC药品排行，OTC常用药品有哪些","药品什么牌子好？品牌TOP榜权威发布2026年药品十大品牌名录；居前十的有：三九999、同仁堂、广药白云山、云南白药、太极药业TAIJI、修正、京都念慈菴、天士力TASLY、扬子江药业、仁和药业RenHe等，【行业品牌名录】基于大数据与人工智能技术，整合300+国际权威榜单及企业申报数据，通过算法分析市场占有率、创新力等12项指标，并解析超百万条舆情信息，采用加权模型（算法60%+专家30%+用户10%）生成动态排名。数据月度更新，申报需通过ISO认证审核，排名不分先后，仅供参考。",1411,"医药用品",20,9,1054]